ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,106, issued on Aug. 26, was assigned to H. Lundbeck A/S (Valby, Denmark).
"Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease" was invented by Morten Jorgensen (Valby, Denmark), Erhad Ascic (Valby, Denmark), Karin Sjodin (Valby, Denmark), Klaus Gjervig Jensen (Valby, Denmark) and Jarkko Tapani Rautio (Valby, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of formula (Id) that are prodrugs of catecholamine for use in treatment of neurodegenerative diseases and disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention an...